Effect of biologic lung volume reduction (BLVR) therapy on BODE at 6 and 12 weeks

V. Pinto-Plata, L. Kenney, C. J. Criner, M. Gottfried, M. M. Dransfield, C. Strange, Y. Refaely, B. Celli (Boston, MA, Philadelphia, PA, Phoenix, AZ, Birmingham, AL, Charleston, SC, United States Of America; Petah Tikva, Israel)

Source: Annual Congress 2008 - COPD
Session: COPD
Session type: E-Communication Session
Number: 4668
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Pinto-Plata, L. Kenney, C. J. Criner, M. Gottfried, M. M. Dransfield, C. Strange, Y. Refaely, B. Celli (Boston, MA, Philadelphia, PA, Phoenix, AZ, Birmingham, AL, Charleston, SC, United States Of America; Petah Tikva, Israel). Effect of biologic lung volume reduction (BLVR) therapy on BODE at 6 and 12 weeks. Eur Respir J 2008; 32: Suppl. 52, 4668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Responses to polymeric lung volume reduction (PLVR) therapy at 6 months in patients with GOLD stage III emphysema
Source: Annual Congress 2010 - Interventions for obstructive lung diseases
Year: 2010

Effect of polymeric lung volume reduction (PLVR) therapy on composite COPD outcome measures
Source: Annual Congress 2010 - COPD: symptoms and staging
Year: 2010



Short term change in modified BODE (mBODE) in severe emphysema patients predicts mortality with lung volume reduction surgery (LVRS)
Source: Eur Respir J 2006; 28: Suppl. 50, 569s
Year: 2006

Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020


CAPTAIN: Effects of lung function at screening (FEV1 % predicted) as a continuous variable on treatment outcomes
Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science
Year: 2021



Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF)
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008

Polymeric lung volume reduction (PLVR) therapy for advanced homogeneous emphysema
Source: Annual Congress 2010 - New toys, old problems: extrapleural lung volume reduction, sedation and comfort in bronchoscopy
Year: 2010

Airway morphometry in hamsters (H) with elastase-induced emphysema (EIE). Effects of lung volume reduction surgery (LVRS)
Source: Eur Respir J 2001; 18: Suppl. 33, 31s
Year: 2001

Change in lung clearance index (LCI) following intravenous antibiotic intervention in children with CF
Source: Annual Congress 2008 - Respiratory physiology in health and disease
Year: 2008


6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Predictive value of 6 MWD and derived indices 3 months after initial PAH therapy for the necessity of a combination therapy in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013

Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Glucocorticosteroid reversibility testing with oral prednisone (²steroid trial²) for 4 weeks: time-response study using serial spirometry and 6-minute walk distance (6MWD) in patients with moderate to severe stable COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004

Mechanisms of improved gas exchange after lung volume reduction surgery (LVRS)
Source: Eur Respir J 2004; 24: Suppl. 48, 324s
Year: 2004

Lung volume reduction surgery (LVRS) after endoscopic lung volume reduction (ELVR) in severe emphysema – A case series
Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree
Year: 2012

Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016



Four weeks of treatment with n-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Effects of pulmonary rehabilitation following single (SLTX) or double (DLTX) lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 355s
Year: 2001

Impact of lung volume reduction surgery versus rehabilitation on quality of life
Source: Eur Respir J 2004; 23: 275-280
Year: 2004



Lung clearance index (LCI) at age 1-4 years vs lung function and chest X-ray (CXR) scores at age 7 years in children with CF
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011